Location History:
- Newhouse-Scotland, GB (2010)
- Newhouse, GB (2008 - 2011)
Company Filing History:
Years Active: 2008-2011
Title: Zoran Rankovic: Innovator in Pharmaceutical Chemistry
Introduction
Zoran Rankovic is a notable inventor based in Newhouse, GB, recognized for his contributions to pharmaceutical chemistry. He holds a total of six patents, showcasing his innovative approach to developing new medicinal compounds. His work primarily focuses on creating derivatives that target various diseases, particularly those related to the central nervous system and other health conditions.
Latest Patents
Among his latest patents, Rankovic has developed 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives. This invention relates to pharmaceutical compositions that utilize these derivatives for treating cathepsin S related diseases, including atherosclerosis, obesity, inflammation, and immune disorders such as rheumatoid arthritis, psoriasis, cancer, and chronic pain. Additionally, he has patented 1-arylsulfonyl-3-substituted indole and indoline derivatives, which are useful in treating central nervous system disorders. These derivatives are designed to address conditions such as psychosis, schizophrenia, manic depression, neurological disorders, cognitive enhancement, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, and Huntington's disease.
Career Highlights
Zoran Rankovic is currently associated with N.V. Organon, where he continues to advance his research and development efforts in the pharmaceutical field. His innovative work has significantly contributed to the understanding and treatment of complex medical conditions.
Collaborations
Throughout his career, Rankovic has collaborated with esteemed colleagues, including Jiaqiang Cai and Philip Stephen Jones. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.
Conclusion
Zoran Rankovic's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to improving healthcare. His work continues to pave the way for new treatments that address critical health challenges.